OTCPK:UNVC

Stock Analysis Report

Executive Summary

Univec, Inc., through its subsidiaries, produces, licenses, and markets medical products in the United States and internationally.

Snowflake

Fundamentals

Adequate balance sheet with weak fundamentals.

Risks

  • Univec has significant price volatility in the past 3 months.
  • Univec's last earnings update was 4321 days ago.
  • Univec is not covered by any analysts.

Share Price & News

How has Univec's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-5.1%

OTCPK:UNVC

0.5%

US Medical Equipment

-0.02%

US Market


1 Year Return

646.5%

OTCPK:UNVC

9.9%

US Medical Equipment

1.6%

US Market

UNVC outperformed the Medical Equipment industry which returned 9.7% over the past year.

UNVC outperformed the Market in United States of America which returned 1.9% over the past year.


Share holder returns

UNVCIndustryMarket
7 Day-5.1%0.5%-0.02%
30 Day21.2%0.09%2.7%
90 Day15.7%2.0%1.4%
1 Year646.5%646.5%10.8%9.9%3.8%1.6%
3 Year14084.0%14084.0%69.0%63.9%45.2%35.8%
5 Year6992.0%6992.0%136.2%109.3%61.8%44.1%

Price Volatility Vs. Market

How volatile is Univec's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Univec undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether Univec is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Univec has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Examine Univec's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Univec regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Univec expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.1%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Univec has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Examine Univec's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Univec's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Univec performed over the past 5 years?

0.2%

Historical Healthcare annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Univec has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

Financial Health

How is Univec's financial position?


In this section we usually analyse Univec's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Univec has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of UNVC’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when Univec's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is Univec's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Univec's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Univec's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Univec has not reported any payouts.

Unable to verify if Univec's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Univec has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Univec's salary, the management and board of directors tenure and is there insider trading?

17.0yrs

Average management tenure


CEO

David Dalton (70yo)

17.7yrs

Tenure

US$133,073

Compensation

Dr. David Dalton serves as Chairman, President and Chief Executive Officer of Wellness Teladoc, and Pharmacy Services Inc. Dr. Dalton founded Health Resources, Inc. in 1983 and has been its President and C ...


Management Age and Tenure

17.0yrs

Average Tenure

70yo

Average Age

The average tenure for the Univec management team is over 5 years, this suggests they are a seasoned and experienced team.


Board Age and Tenure

16.7yrs

Average Tenure

71yo

Average Age

The average tenure for the Univec board of directors is over 10 years, this suggests they are a seasoned and experienced board.


Insider Trading

No 3 month open market individual insider trading information.


Management Team

  • David Dalton (70yo)

    CEO, President & Director

    • Tenure: 17.7yrs
    • Compensation: US$133.07k
  • Michael Lesisko (70yo)

    Chief Financial Officer

    • Tenure: 17yrs
    • Compensation: US$12.50k
  • Raphael Langford (75yo)

    Chief Operating Officer and Executive Vice President

    • Tenure: 16.4yrs
    • Compensation: US$13.33k

Board Members

  • David Dalton (70yo)

    CEO, President & Director

    • Tenure: 17.7yrs
    • Compensation: US$133.07k
  • S. Grass (85yo)

    Chairman

    • Tenure: 17.3yrs
  • William Wooldridge (72yo)

    Director

    • Tenure: 16.1yrs
  • Bobby Cohen (58yo)

    Chairman of The Financial Advisory Board

    • Tenure: 5.2yrs

Company Information

Univec, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Univec, Inc.
  • Ticker: UNVC
  • Exchange: OTCPK
  • Founded: 1992
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: US$6.225m
  • Shares outstanding: 438.84m
  • Website: https://www.univec.com

Location

  • Univec, Inc.
  • 822 Guilford Avenue
  • Suite 208
  • Baltimore
  • Maryland
  • 21202
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
UNVCOTCPK (Pink Sheets LLC)YesCommon StockUSUSDApr 1997

Biography

Univec, Inc., through its subsidiaries, produces, licenses, and markets medical products in the United States and internationally. It primarily provides auto-disable and safety syringes. The company offers ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/18 23:42
End of Day Share Price2019/09/18 00:00
Earnings2007/09/30
Annual Earnings2006/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.